PGGM Investments bought a new position in HCA Healthcare Inc (NYSE:HCA) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 361,870 shares of the company’s stock, valued at approximately $31,555,000. PGGM Investments owned 0.10% of HCA Healthcare at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the company. BlackRock Inc. increased its stake in HCA Healthcare by 2,549.4% in the first quarter. BlackRock Inc. now owns 20,099,811 shares of the company’s stock worth $1,788,682,000 after buying an additional 19,341,168 shares during the last quarter. FMR LLC increased its stake in HCA Healthcare by 15.8% in the first quarter. FMR LLC now owns 7,763,884 shares of the company’s stock worth $690,908,000 after buying an additional 1,059,925 shares during the last quarter. Old Mutual Global Investors UK Ltd. increased its stake in HCA Healthcare by 44.6% in the first quarter. Old Mutual Global Investors UK Ltd. now owns 1,627,311 shares of the company’s stock worth $144,814,000 after buying an additional 501,591 shares during the last quarter. Morgan Stanley increased its stake in HCA Healthcare by 51.7% in the first quarter. Morgan Stanley now owns 1,186,998 shares of the company’s stock worth $105,630,000 after buying an additional 404,599 shares during the last quarter. Finally, Vanguard Group Inc. increased its stake in HCA Healthcare by 1.9% in the first quarter. Vanguard Group Inc. now owns 19,576,992 shares of the company’s stock worth $1,742,157,000 after buying an additional 361,027 shares during the last quarter. Institutional investors own 74.54% of the company’s stock.

HCA Healthcare Inc (HCA) opened at 78.87 on Monday. The company’s 50-day moving average price is $84.93 and its 200 day moving average price is $84.50. HCA Healthcare Inc has a 52-week low of $67.00 and a 52-week high of $91.03. The stock has a market capitalization of $29.60 billion, a P/E ratio of 10.57 and a beta of 0.67.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, July 25th. The company reported $1.75 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.80 by $0.05. The firm had revenue of $10.73 billion during the quarter, compared to analyst estimates of $10.76 billion. The firm’s revenue for the quarter was up 4.0% compared to the same quarter last year. During the same period in the previous year, the business posted $1.66 earnings per share. On average, equities research analysts anticipate that HCA Healthcare Inc will post $7.20 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “PGGM Investments Takes Position in HCA Healthcare Inc (NYSE:HCA)” was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another publication, it was copied illegally and republished in violation of international copyright laws. The correct version of this piece can be viewed at https://www.thecerbatgem.com/2017/08/07/pggm-investments-invests-31-56-million-in-hca-holdings-inc-nysehca-updated.html.

A number of analysts have commented on HCA shares. Cantor Fitzgerald reiterated a “buy” rating and set a $95.00 target price on shares of HCA Healthcare in a research report on Monday, April 17th. Argus began coverage on HCA Healthcare in a research report on Wednesday, June 28th. They issued a “buy” rating and a $100.00 price objective on the stock. Morgan Stanley began coverage on HCA Healthcare in a research report on Tuesday, June 6th. They issued an “equal weight” rating and a $90.00 price objective on the stock. Leerink Swann upgraded HCA Healthcare from a “market perform” rating to an “outperform” rating and upped their price objective for the company from $92.00 to $100.00 in a research report on Tuesday, June 6th. Finally, Zacks Investment Research downgraded HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Tuesday, April 18th. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and twelve have given a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $93.50.

In related news, SVP Jane D. Englebright sold 5,005 shares of HCA Healthcare stock in a transaction on Wednesday, May 10th. The stock was sold at an average price of $85.31, for a total transaction of $426,976.55. Following the completion of the sale, the senior vice president now owns 17,351 shares of the company’s stock, valued at $1,480,213.81. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, SVP Jana Joustra Davis sold 8,302 shares of HCA Healthcare stock in a transaction on Thursday, May 11th. The shares were sold at an average price of $85.02, for a total value of $705,836.04. Following the sale, the senior vice president now directly owns 36,589 shares of the company’s stock, valued at approximately $3,110,796.78. The disclosure for this sale can be found here. In the last ninety days, insiders sold 151,424 shares of company stock valued at $12,787,290. 2.90% of the stock is currently owned by insiders.

About HCA Healthcare

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Stock Ratings for HCA Healthcare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare Inc and related stocks with our FREE daily email newsletter.